Speaking at the J.P. Morgan Healthcare Conference, Mike Mahoney, CEO of Boston Scientific a Marlborough, Mass.-based medical device company, said the company derived about 10% of its total sales from emerging markets in Brazil, Russia, India and China during the 3-months ended Sept. 30, 2014 — an 18% increase from the same period in 2013.
Mass Device reports that Boston Scientific is looking double its emerging markets presence over the next 2 years as it seeks to catch up with larger competitors; therefore expanding its presence in emerging markets is one of five strategic imperatives Mahoney said the company is putting forward in 2015 and beyond.
